Both technologies were developed by scientists at the University of California, Los Angeles, and the agreement gives LA-based NPH the exclusive global licenses to the delivery mechanisms.
Double nanoemulsions made possible
The first of the developments is a system for creating nanoemulsions, including the capacity to create double nanoemulsions, which has proved difficult in the past.
According to the company, nanoemulsions are highly adaptable liquid delivery system that can be tailored to many different applications.
Through the agreement, NPH hopes to develop a number of nanoemulsion delivery applications for the cosmetics and pharmaceutical industries.
Nanoencapsulation
The second of the technologies covered by the agreement is a method for synthesising copolypeptides.
These materials can then be assembled into nanoscale structures for encapsulating active ingredients.
Examples include hydrogels whose nanofibrous structure can serve as a delivery depot or bioactive scaffold in therapeutic and cosmetic formulations, according to the company.
It hopes that adding these two offerings to their technology portfolio will significantly enlarge the number of markets in which it operates.
“These technologies facilitate NPH’s quest to be the premier nano controlled-delivery company. This now opens up to NanoPacific a broader range of sophisticated and targeted applications in the Biomedical (diaganostics and therapeutics), Cosmetics, Industrial, Environmental and Food and Agricultural markets,” said NPH CEO Joseph A. Boystak.
A previous breakthrough regarding porous nanoparticles for controlled delivery made by scientists at UCLA is also licensed to the company.
The porous particles are capable of storing and selectively releasing molecules through nanoscale gates that can be opened and closed at will, explained the company.